AlphaQuest LLC Boosts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

AlphaQuest LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 518.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,182 shares of the medical equipment provider’s stock after purchasing an additional 1,829 shares during the quarter. AlphaQuest LLC’s holdings in Intuitive Surgical were worth $1,139,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Massachusetts Financial Services Co. MA purchased a new stake in Intuitive Surgical in the 3rd quarter worth approximately $558,807,000. Proficio Capital Partners LLC increased its holdings in shares of Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after buying an additional 948,902 shares during the last quarter. FMR LLC increased its holdings in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth $313,769,000. Finally, Wilmington Savings Fund Society FSB increased its holdings in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Mark Brosius sold 489 shares of Intuitive Surgical stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $533.18, for a total transaction of $260,725.02. Following the transaction, the senior vice president now directly owns 2,091 shares of the company’s stock, valued at approximately $1,114,879.38. This trade represents a 18.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,579 shares of company stock valued at $7,756,844. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on ISRG shares. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Jefferies Financial Group increased their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Piper Sandler reissued an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Evercore ISI increased their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Down 3.8 %

Shares of Intuitive Surgical stock opened at $518.26 on Monday. The company’s fifty day simple moving average is $571.36 and its two-hundred day simple moving average is $531.85. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The firm has a market cap of $184.59 billion, a PE ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.